Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001959173-25-000885
Filing Date
2025-02-11
Accepted
2025-02-11 15:40:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 3568
  Complete submission text file 0001959173-25-000885.txt   5003
Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 857-259-5340
Voyager Therapeutics, Inc. (Subject) CIK: 0001640266 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-37625 | Film No.: 25609520
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O VOYAGER THERAPEUTICS, INC. 64 SIDNEY STREET CAMBRIDGE MA 02139
Business Address
Carter Todd Alfred (Reporting) CIK: 0001944011 (see all company filings)

Type: 144